No Data
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Contrasting Zentalis Pharmaceuticals (NASDAQ:ZNTL) and Advaxis (NASDAQ:ADXS)
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Rating) and Advaxis (NASDAQ:ADXS – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Stock Price Up 6.7%
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) rose 6.7% during trading on Tuesday . The stock traded as high as $21.84 and last traded at $21.58. Approximately 871 shares were traded dur
Press Release: Zentalis Pharmaceuticals Promotes Co-Founder Kevin Bunker, Ph.D. to Chief Scientific Officer
Zentalis Pharmaceuticals Promotes Co-Founder Kevin Bunker, Ph.D. to Chief Scientific Officer NEW YORK and SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Zentalis(TM) Pharmaceuticals, Inc. (Nasdaq: ZNT
Moore Kuehn, PLLC Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm
Zentalis Pharmaceuticals Appoints Carrie Brownstein as Chief Medical Officer
Cam Gallagher Sells 12,500 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Stock
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) President Cam Gallagher sold 12,500 shares of the firm's stock in a transaction that occurred on Thursday, September 15th. The shares were so
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Trading Down 15.5%
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating)'s stock price traded down 15.5% during trading on Tuesday . The stock traded as low as $26.24 and last traded at $26.34. 13,199 shares were t
Zentalis Pharmaceuticals (NASDAQ:ZNTL) Sees Strong Trading Volume
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) shares saw an uptick in trading volume on Wednesday . 32,512 shares were traded during mid-day trading, a decline of 95% from the previous s
BioAffinity, NeuroOne Top Healthcare Gainers; Altimmune, Comera Lead Losers' Pack
Gainers: bioAffinity Technologies (BIAF) +54%. NeuroOne Medical Technologies (NMTC) +14%. RVL Pharmaceuticals (RVLP) +13%. Bausch Health Companies (BHC) +9%. Aditxt (ADTX) +5%. Losers: Altimmune (AL
Loading...
